Breast Cancer Risk and Blood Tests: What Biomarkers Reveal

Quick answer

A mammogram is the main screening tool for breast cancer. Doctors recommend it from age 40 to 50, depending on the guideline. Blood-based tumor markers, like CA 15-3, help monitor cancer that is already diagnosed. They do not screen for new cancer. BRCA1 and BRCA2 genetic testing can flag inherited risk in certain families. Hormone levels affect breast cancer biology. But they are not a screening test on their own.

How breast cancer screening works

Mammography is the gold standard. This X-ray of your breast tissue is the single most sensitive test for finding breast cancer. Do it every year or two. Start between 40 and 50, depending on the guideline you follow. Newer 3D mammograms are becoming the norm.

Breast ultrasound often supports a mammogram. It helps most with dense breast tissue. It uses no radiation. It can catch some cancers a mammogram misses.

Breast MRI is more sensitive than a mammogram. Doctors save it for higher-risk women. This includes those with a BRCA mutation or a strong family history. It also produces more false alarms in the general population.

Clinical breast exams help too. So does simple breast awareness, knowing what feels normal for you.

Where blood tests fit

CA 15-3 and CA 27-29 are tumor markers linked to breast cancer. Doctors use them to monitor cancer that is already diagnosed. This matters most for cancer that has spread. They are not used for screening. They miss too many early cases, and they produce too many false alarms.

CEA sometimes rises with breast cancer. It rises with many other cancers too. Like the markers above, it is for monitoring, not screening.

Estradiol and progesterone reflect your hormone status. This affects breast cancer biology. They are not screening tests. They help guide treatment once cancer is already found.

Multi-cancer blood tests include a breast cancer signal. This is part of a broader panel. Their accuracy for early breast cancer is still modest. They cannot replace a mammogram.

Genetic testing for BRCA1 and BRCA2 can help. These are the best-known hereditary breast cancer genes. Testing can identify women who need closer monitoring. Other genes, like PALB2 and CHEK2, get tested more often now too.

BRCA1 and BRCA2 testing

When it makes sense: a strong family history of breast or ovarian cancer. A breast cancer diagnosis at a young age. A known BRCA mutation in your family. Or triple-negative breast cancer.

What a positive result means: your lifetime risk of breast and ovarian cancer rises a lot. There is a 50% chance of passing the mutation to each child. It usually leads to closer screening. Sometimes it leads to risk-lowering medicine or surgery. Testing close family members often makes sense too.

Getting tested: this usually goes through genetic counseling. It is based on your personal risk, not a routine test for everyone.

Managing a BRCA mutation: more frequent screening, often a mammogram plus an MRI. Risk-lowering surgery is an option for some women. So is risk-lowering medicine, like tamoxifen. A specialist team supports the whole plan.

Hormones and breast cancer

Lifetime estrogen exposure shapes your breast cancer risk. This includes an early first period, and a late menopause. It also includes never having children, or having your first child later in life. Hormone therapy after menopause plays a role too.

Hormone blood tests are not screening tools. They shape biology. But they do not reliably predict who will get cancer. Once cancer is found, hormone receptor testing on the tumor itself guides treatment. This test uses tumor tissue, not blood.

What raises your risk

Strong risk factors: family history, especially in a close relative or at a young age. A BRCA or other gene mutation. A personal history of breast cancer, or certain past biopsy findings. Past chest radiation.

Moderate risk factors: older age, being female, and an early first period or late menopause. Never having children, or having them later, adds risk too. Hormone therapy after menopause plays a role. So do heavy alcohol use and extra weight after menopause.

Modest risk factors: dense breast tissue, smoking, and certain dietary patterns.

How to lower your risk

Keep a healthy weight, especially after menopause. Exercise regularly. Limit alcohol. Breastfeeding, if you have that option, modestly lowers risk. Avoid smoking. Talk with your doctor about hormone therapy, since this is a personal decision.

Follow your screening schedule closely. Add an MRI if you are high-risk. Medicine like tamoxifen is one option. Preventive surgery is another. High-risk women should discuss both with a specialist.

Symptoms worth a prompt check

See a doctor promptly for a new lump or thickening. Watch for skin changes too, like dimpling or redness. Nipple changes, including discharge, are worth a check. So are ongoing breast pain, unexplained asymmetry, or swollen lymph nodes near your armpit or collarbone. Most of these turn out to be harmless, but always worth checking.

Why this matters for the region

Breast cancer rates are rising across the region. Diagnosis often happens at a later stage here. Younger women get diagnosed more often too, compared with Western countries. Screening access still varies by area. Many women benefit from starting mammograms around 40. Start even earlier with a strong family history.

See how &you Labs supports your broader preventive health plan. Ready to check your own numbers? Book a &you Labs panel.

Frequently asked questions

Can a blood test detect breast cancer?

Not well, as a screening tool. Mammography remains the gold standard. Blood tumor markers are for monitoring cancer that is already known.

Should I get BRCA testing?

It is worth considering with a strong family history of breast or ovarian cancer. It also fits an early-onset case in your family, or a known family mutation. Genetic counseling usually comes first.

When should I start mammograms?

Some guidelines say 40. Others say 50. Higher-risk women often start earlier. Talk with your doctor about what fits your history.

Are 3D mammograms better than 2D?

Generally yes. They catch more, with fewer false alarms. This matters most with dense breast tissue. They are becoming the standard option.

Does hormone therapy cause breast cancer?

Combined hormone therapy modestly raises risk with long-term use. Estrogen-only therapy behaves differently. For many symptomatic women under 60, the benefits often outweigh the risk. This is a personal decision to make with your doctor.

Key takeaways

• Breast cancer screening relies mainly on mammograms, not blood tests.
• Blood tumor markers like CA 15-3 monitor known cancer. They do not screen for it.
• BRCA1 and BRCA2 testing can flag inherited risk in certain families.
• Breast cancer is rising across the region, often diagnosed at a younger age here than in the West.
• Lifestyle factors like weight, exercise, and alcohol modestly shift your risk.